GI
BIIB icon

GLG Inc’s Biogen BIIB Stock Holding History

GLG Inc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$8.28M Sell
29,585
-16,425
-36% -$4.25M 0.22% 133
2013
Q3 		$11.1M Buy
46,010
+11,329
+33% +$2.54M 0.22% 132
2013
Q2 		$7.46M Buy
+34,681
New +$7.41M 0.18% 111

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GLG Inc's BIIB Position: Q4 2013 in Review

GLG Inc reduced its Biogen (BIIB) stake by 36% in Q4 2013, selling an estimated $4.25M and leaving 29,585 shares worth $8.28M. The position accounts for 0.22% of the portfolio, ranked #133.

GLG Inc first reported a position in BIIB in Q2 2013 and has held it in 3 quarters since. The position peaked at $11.1M in Q3 2013. 738 funds tracked by Wall St. Rank hold BIIB as of Q4 2013.

  • GLG Inc held 29,585 shares of Biogen worth $8.28M as of Q4 2013.
  • GLG Inc sold 16,425 Biogen shares in Q4 2013, an estimated $4.25M.
  • Biogen made up 0.22% of GLG Inc's portfolio in Q4 2013, its #133 holding.
  • GLG Inc first reported a position in Biogen in Q2 2013 and has held it in 3 quarters since.
  • GLG Inc's Biogen position peaked at $11.1M in Q3 2013.
  • 738 funds tracked by Wall St. Rank held Biogen as of Q4 2013.

Based on GLG Inc's 13F filing for Q4 2013, filed 14 Feb 2014.